Steve Grauer - Concepedia

Author

Steve Grauer

Princeton University

Also Known As

S.M. Grauer, Steve Grauer

Publications

926

Citations

H-Index

Concepts

All Affiliations

Princeton University BioCrea (Germany)University of Pennsylvania Pfizer (United States)

About

Steve Grauer is an author at Princeton University specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	724
2	Natural Sciences	2	2	102
3	Social Sciences	2	2	596
4	Biochemistry	2	2	102
5	Chemical Biology	1	1	72

Steve Grauer

Publications

926

Citations

H-Index

Page 1

	Year	Citations
Activation of estrogen receptor-β regulates hippocampal synaptic plasticity and improves memory Feng Liu, Mark L. Day, Luis C Muñiz, Nature Neuroscience Synaptic PlasticityCognitive ScienceMedicineHormonal ReceptorNeuroendocrine Mechanism	2008	496
ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities Feng Liu, Steve Grauer, Cody Kelley, Journal of Pharmacology and Experimental Therapeutics	2008	181
Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents Sharon Rosenzweig‐Lipson, Annmarie L. Sabb, Gary Stack, Psychopharmacology Molecular PharmacologyPsychiatryFunctional SelectivityAntidepressant-like EffectsMedicine	2007	100
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors Michael S. Malamas, Yike Ni, James Erdei, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetPharmaceutical ScienceBiochemistryMedicine	2011	72
Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonists Containing a Urea Moiety: Identification and Characterization of the Potent, Selective, and Orally Efficacious Agonist 1-[6-(4-Fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) Urea (SEN34625/WYE-103914) Chiara Ghiron, Simon N. Haydar, Suzan Aschmies, Journal of Medicinal Chemistry Brain PenetrationPharmacotherapyMedicinal ChemistryNicotineNeurology	2010	30
Novel triazines as potent and selective phosphodiesterase 10A inhibitors Michael S. Malamas, Hans Stange, Rudolf Schindler, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryMedicinePharmacotherapyDrug Development	2012	26
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease Peter Bloomingdale, Daniela Bumbaca-Yadav, Jonathan A. Sugam, Frontiers in Pharmacology	2022	21

Page 1